INS and diabetes mellitus: The 7-iF is broadly based on the EMGQN guidelines [5] but, unlike the latter, it includes T1D autoimmune markers and insulin treatment in the attempt to exclude patients with type 1 diabetes, which is the most prevalent form of diabetes (> 80%) in young individuals [11].